Lijun Xue

1.6k total citations
51 papers, 1.3k citations indexed

About

Lijun Xue is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Lijun Xue has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Surgery. Recurrent topics in Lijun Xue's work include RNA modifications and cancer (7 papers), Metal-Catalyzed Oxygenation Mechanisms (6 papers) and DNA Repair Mechanisms (4 papers). Lijun Xue is often cited by papers focused on RNA modifications and cancer (7 papers), Metal-Catalyzed Oxygenation Mechanisms (6 papers) and DNA Repair Mechanisms (4 papers). Lijun Xue collaborates with scholars based in China, United States and Taiwan. Lijun Xue's co-authors include Yun Yen, Xiyong Liu, Bingsen Zhou, Xiaobei Mao, Longbang Chen, Xiaoyuan Chu, Quansheng Su, Peiguo Chu, Yong Lin and Lili Ren and has published in prestigious journals such as Gastroenterology, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Lijun Xue

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijun Xue China 23 691 413 260 192 176 51 1.3k
Nicolas Germain France 20 519 0.8× 160 0.4× 275 1.1× 104 0.5× 265 1.5× 41 1.4k
Hui‐Ju Wang China 21 817 1.2× 289 0.7× 476 1.8× 118 0.6× 184 1.0× 82 1.4k
Mariko Fukuma Japan 16 707 1.0× 390 0.9× 107 0.4× 263 1.4× 169 1.0× 35 1.3k
Jinyang Wang China 17 584 0.8× 115 0.3× 317 1.2× 117 0.6× 82 0.5× 47 1.2k
Guanmin Jiang China 17 675 1.0× 399 1.0× 242 0.9× 77 0.4× 100 0.6× 19 1.2k
Jinyu Li China 19 742 1.1× 355 0.9× 272 1.0× 116 0.6× 138 0.8× 50 1.5k
Mohammed Tanjimur Rahman Japan 18 639 0.9× 190 0.5× 225 0.9× 73 0.4× 92 0.5× 63 1.1k
Priya Bhardwaj United States 16 388 0.6× 497 1.2× 244 0.9× 136 0.7× 86 0.5× 42 1.3k

Countries citing papers authored by Lijun Xue

Since Specialization
Citations

This map shows the geographic impact of Lijun Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Xue more than expected).

Fields of papers citing papers by Lijun Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Xue. The network helps show where Lijun Xue may publish in the future.

Co-authorship network of co-authors of Lijun Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Xue. A scholar is included among the top collaborators of Lijun Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Xue. Lijun Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Gao‐Min, Xiaoyu Ding, Lijun Xue, et al.. (2024). miR-520e and its promoter region DNA methylation as potential biomarkers in atherosclerosis. Biochemistry and Cell Biology. 102(5). 385–393. 1 indexed citations
3.
Xue, Lijun, et al.. (2024). Structure characterization and intestinal immune promotion effect of polysaccharide purified from Alhagi camelorum Fisch. International Journal of Biological Macromolecules. 269(Pt 2). 132077–132077. 9 indexed citations
4.
Xue, Lijun, Yuan Xie, Dandan Liu, et al.. (2024). Effects of Alhagi maurorum Medik polysaccharide derived from different regions on the intestinal immune functions of lambs. Frontiers in Pharmacology. 15. 1422461–1422461. 2 indexed citations
5.
Liu, Liang, et al.. (2021). Submucosal hematoma with a wide range of lesions, severe condition and atypical clinical symptoms: A case report. World Journal of Clinical Cases. 9(20). 5683–5688. 1 indexed citations
6.
Gu, Yanhong, Lijun Xue, Fuxi Zhen, et al.. (2020). 175P A study of neoadjuvant sintilimab combined with triplet chemotherapy of lipo-paclitaxel, cisplatin, and S-1 for resectable esophageal squamous cell carcinoma (ESCC). Annals of Oncology. 31. S1307–S1308. 16 indexed citations
7.
Xue, Lijun, Xiaobei Mao, Xiaobei Liu, et al.. (2019). Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma. Cancer Biology & Therapy. 20(6). 866–876. 16 indexed citations
8.
Wu, Rong, et al.. (2017). The value of use of z-score as a predictor of prognosis of the extrauterine growth restriction. Biomedical Research-tokyo. 28(13). 5836–5840. 1 indexed citations
9.
Xue, Lijun, et al.. (2017). Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma. Cancer Medicine. 6(6). 1424–1436. 65 indexed citations
10.
Xie, Tao, Jian Geng, Ye Wang, et al.. (2016). FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Oncotarget. 8(5). 8574–8589. 59 indexed citations
11.
Guo, Jun, Yu Sun, Lijun Xue, et al.. (2016). Effect of CPAP therapy on cardiovascular events and mortality in patients with obstructive sleep apnea: a meta-analysis. Sleep And Breathing. 20(3). 965–974. 55 indexed citations
12.
Shi, Xiaoguang, Lijun Xue, Xu Jin, et al.. (2016). Different expression of sodium–iodide importer (NIS) between lactating breast and thyroid tissues may be due to structural difference of thyroid-stimulating hormone receptor (TSHR). Journal of Endocrinological Investigation. 40(1). 41–48. 3 indexed citations
13.
Chen, Wei, Li Xu, Zhiyi Wang, et al.. (2014). Haplotype Analysis of the XRCC1 Gene and Laryngeal Cancer. Genetic Testing and Molecular Biomarkers. 18(7). 525–529. 4 indexed citations
14.
Liu, Xiyong, Sean K. Wang, Keqiang Zhang, et al.. (2014). Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers. Carcinogenesis. 36(2). 232–242. 29 indexed citations
15.
Kuo, Mei-Ling, Lijun Xue, Terence T. Yen, et al.. (2012). RRM2B Suppresses Activation of the Oxidative Stress Pathway and is Up-regulated by P53 During Senescence. Scientific Reports. 2(1). 822–822. 32 indexed citations
16.
Liu, Xiyong, Lily Lai, Xiaochen Wang, et al.. (2011). Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer. Cancer Research. 71(9). 3202–3213. 52 indexed citations
17.
Chen, Longbang, et al.. (2011). Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer. Journal of Surgical Oncology. 105(6). 520–528. 49 indexed citations
18.
Xue, Lijun, Jihong Yang, Quansheng Su, Hai Wang, & Chang Liu. (2010). Synchronous Gastric Carcinoma and Nodal Malignant Lymphoma: A Rare Case Report and Literature Review. Case Reports in Oncology. 3(2). 223–230. 6 indexed citations
19.
Xue, Lijun, et al.. (2010). Rapid Remission in Peripheral T-Cell Lymphoma of the Nasal Type by the Bortezomib plus CHOP Therapy. Case Reports in Medicine. 2010. 1–4.
20.
Xue, Lijun, et al.. (2001). [The value of medical thorascopy].. PubMed. 24(4). 198–200. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026